Back to results
US 2016/0250182 A1Published application
Rab7l1 interacts with lrrk2 to modify intraneuronal protein sorting and parkinson's disease risk
AssigneeThe Trustees of Columbia University In the City of
InventorAsa ABELIOVICH
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and compositions for treating Parkinson's Disease in a subject.
Claims7
A method for treating Parkinson's Disease (PD) in a subject, the method comprising administering to a subject in need thereof a therapeutic amount of a retromer complex-stabilizing compound, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.